IO
LIVE

Serial Number

79301305

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

Jul 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IO Trademark

Serial Number: 79301305 • Registration: 6451089

IO is a trademark filed by Bit Bio Limited on July 9, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

July 9, 2020

Registration Date

August 17, 2021

Published for Opposition

June 1, 2021

Goods & Services

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely, biological research; scientific services for research, clinical, therapeutic and manufacturing relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and technological consultancy relating to drug screening; scientific and technological consultancy relating to genetic screening; scientific and technological consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use, not for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for research use; cell preparations for drug screening for research use; genetically or otherwise modified cells for research use; cells which are propagated, cultivated and expended in bioreactors for research use

Pharmaceuticals in the nature of cell therapeutics for medical and therapeutic use; genetically or otherwise modified cells for medical, therapeutic or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for drug screening for medical, therapeutic or clinical use; cell preparations for genetic testing, screening for medical, therapeutic or clinical purposes; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; tissue culture media in the nature of cell growth, cell growth factors, growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical purposes; cell separation reagents for medical, therapeutic or clinical purposes; dietary supplements; protein supplements; nutrition supplements

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program and algorithm for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical use; magnetic cell separation laboratory equipment, namely, apparatus for the separation of cell populations for medical or clinical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant dna technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 31, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 31, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 17, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 17, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 8, 2021 MAFR
ASSIGNED TO EXAMINER
Jan 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR